PT - JOURNAL ARTICLE ED - , TI - Review: rosiglitazone increases risk of MI but does not differ from other drugs for CV death in type 2 diabetes AID - 10.1136/ebm.12.6.169 DP - 2007 Dec 01 TA - Evidence Based Medicine PG - 169--170 VI - 12 IP - 6 4099 - http://ebm.bmj.com/content/12/6/169.short 4100 - http://ebm.bmj.com/content/12/6/169.full SO - Evid Based Med2007 Dec 01; 12